AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
Ineffectiveness of pulmonary irradiation in the treatment of leukemic blast crisis
Authors: Rajkumar, SV Fonseca, R Letendre, L
Citation: Sv. Rajkumar et al., Ineffectiveness of pulmonary irradiation in the treatment of leukemic blast crisis, LEUKEMIA, 13(3), 1999, pp. 490-490
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Therneau, TM Kyle, RA Litzow, MR Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma, J CL ONCOL, 17(5), 1999, pp. 1551-1557
Phase II North Central Cancer Treatment Group study of 2-chlorodeoxyadenosine in patients with recurrent glioma
Authors: Rajkumar, SV Burch, PA Nair, S Dinapoli, RP Scheithauer, B O'Fallon, JR Etzell, PS Leitch, JM Morton, RF Marks, RS
Citation: Sv. Rajkumar et al., Phase II North Central Cancer Treatment Group study of 2-chlorodeoxyadenosine in patients with recurrent glioma, AM J CL ONC, 22(2), 1999, pp. 168-171
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 497-503
Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Autologous stem cell transplantation for relapsed and primary refractory myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Autologous stem cell transplantation for relapsed and primary refractory myeloma, BONE MAR TR, 23(12), 1999, pp. 1267-1272
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma
Authors: Rajkumar, SV Fonseca, R Dewald, GW Therneau, TM Lacy, MQ Kyle, RA Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma, CANC GENET, 113(1), 1999, pp. 73-77
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas
Authors: Rajkumar, SV Buckner, JC Schomberg, PJ Pitot, HC Ingle, JN Cascino, TL
Citation: Sv. Rajkumar et al., Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas, NEUROSURGER, 44(1), 1999, pp. 67-73
Screening mammography in women aged 40-49 years
Authors: Rajkumar, SV Hartmann, LC
Citation: Sv. Rajkumar et Lc. Hartmann, Screening mammography in women aged 40-49 years, MEDICINE, 78(6), 1999, pp. 410-416
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma
Authors: Rajkumar, SV Buckner, JC Schomberg, PJ Reid, JM Bagniewski, PJ Ames, MM Cascino, TL Marks, RS
Citation: Sv. Rajkumar et al., Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma, INT J RAD O, 42(5), 1998, pp. 969-975
Risultati: 1-25 | 26-35 |